FRIDAY, June 19 (HealthDay News) -- Cystoscopy and transrectal ultrasound-guided prostate biopsy performed in the office setting appear to pose minimal risk to patients, according to research published in the June issue of Urology.
Surena F. Matin, M.D., of the University of Texas M.D. Anderson Cancer Center in Houston, and colleagues analyzed data from 554 patients who underwent cystoscopy and 367 who underwent the biopsy procedure in 2006 to 2008. The authors initiated the study with a Joint Commission patient-safety universal protocol in mind, which excludes certain minimal-risk procedures.
The investigators discovered that the total patient event rate was 0.76 percent; the most significant adverse event was a case of acute bacterial prostatitis, and others included non-tolerance of a procedure and vasovagal and possible vasovagal response. The total system event rate was 10.97 percent, most often a delay of more than 15 minutes in starting the procedure.
Latest research and happenings
1 post • Page 1 of 1
- Posts: 11027
- Joined: Wed Oct 30, 2002 3:18 pm
- Location: Please give your location so we can help better
Please fill out your signature, click here for how to do it
|HAS THIS SITE HELPED YOU?|
Say Thanks! by making a small donation
PayPal link at end of page ↓